InnoModels' in vivo tumor experimental platform has several remarkable features:
1. Highly accurate simulation: The platform successfully simulates the complexity of tumors in the human body, providing reliable data and results for research. This highly accurate simulation helps to understand more accurately the process of tumor growth, development and metastasis in the human body, providing an important basis for research on tumor occurrence, development, prevention and treatment.
2. Accelerating drug development: Researchers can utilize this platform to more rapidly assess the efficacy and safety of drugs, thereby accelerating the process of drug development. For drug development companies, this can shorten the drug development cycle, reduce R&D costs, accelerate the speed of new drugs to market, and provide better treatment options for patients.

3. Supporting multidisciplinary research: The platform is not only applicable to basic science research, but also widely used in clinical research and translational medicine, providing support for multidisciplinary synergy. This means that researchers from different disciplines can work together to conduct interdisciplinary research using this platform, promoting the in-depth development of tumor research.
4. High Success Rate and Stable Reconstruction: InnoModels Biotechnology has successfully solved the major problems of tumor growth and PBMC (peripheral blood mononuclear cells) antagonism and cycle matching in the immune system tumor model, which makes the experimental success rate of PBMC model up to 85% or more, and the reconstruction process is extremely stable. This high success rate and stability ensures the reliability of experimental data and provides a solid foundation for research.
5. Compatible with most tumor cells: The PBMC-T platform of InnoModels is compatible with most tumor cells, and more than 90% of human-derived tumor cells can be selected from three PBMC donors in a single pre-experiment that can be co-constructed and formally experimented with. This means that the platform is broadly applicable to different types of tumor research.
In conclusion, the InnoModels in vivo tumor experimental platform has a high degree of simulation accuracy, the ability to accelerate drug development, support for multidisciplinary research, as well as a high success rate and stability, while being compatible with most tumor cells. These features make the platform an important tool in the field of tumor research, providing strong support for basic tumor research, clinical research and drug development.